Intrexon Corporation (XON) Stock: Here’s Why It’s Gaining


Intrexon Corporation (XON) is making a move up in the market today. The stock, focused in the biotechnology industry, is presently priced at $6.53 after gaining 8.83% so far in today’s session. When it comes to biotech stocks, there are quite a few aspects that have the ability to cause gains in the market. News tends to be one of the biggest reasons for the movement. Here are the recent headlines associated with XON:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jun-10-19 07:15PM Intrexon Corp (XON) CEO Randal J Kirk Bought $2.5 million of Shares
11:59AM Weekly CEO Buys Highlight
Jun-08-19 09:30AM Intrexon (XON) Up 24.7% Since Last Earnings Report: Can It Continue?
Jun-04-19 07:15PM Intrexon Corp (XON) CEO Randal J Kirk Bought $998,306 of Shares
Jun-03-19 12:45PM Weekly CEO Buys Highlight

However, any time investors are making an investing decision, investors should take a look at far more than news, especially in the speculative biotech space. Here’s what’s happing when it comes to Intrexon Corporation.

The Performance That We’ve Seen From XON

While a move toward the top in a single session, like what we’re seeing from Intrexon Corporation might make some investors excited, that by itself should not be the basis of a decision to, or not to, buy a company’s stock. It’s generally smart to look at trends experienced by the stock just a single session. In the case of XON, here are the trends that we’ve seen:

  • Weekly – Throughout the last 7 days, XON has produced a change in price in the amount of 17.24%.
  • Past Month – The ROI from Intrexon Corporation over the last 30 days works out to 50.46%.
  • Quarterly – Over the past 3 months, the stock has generated a return that comes to 15.99%
  • Past 6 Months – Over the last six months, we’ve seen a performance of -25.54% from the stock.
  • This Year So Far – Since the the first trading session of this year XON has generated a return of -0.15%.
  • Full Year – Lastly, throughout the past year, investors have seen movement that comes to -61.72% from XON. Throughout this period of time, the stock has traded at a high of -67.25% and a low of 65.32%.

Rations That You Should Consider

Looking at various ratios associated with a company generally gives investors a look of just how dangerous and/or rewarding a an investment option may be. Below are some of the important ratios to consider when digging into XON.

Short Ratio – The short ratio is a measure of short interest. As the short ratio climbs, it means that more investors are expecting that the stock is going to tumble. Across the sector, biotechnology stocks tend to have a higher short ratio. On the other hand, we also see quite a few short squeezes in the sector. Nonetheless, in regard to Intrexon Corporation, it’s short ratio clocks in at 14.05.

Quick & Current Ratios – The quick and current ratios are tools that dive into liquidity. Basically, they measure whether or not a company can pay its debts when they come due with only quick assets or current assets. Because many biotech many companies are heavily reliant on the continuation of investor support, the current and quick ratios can seem damning. Nonetheless, several better companies in the biotechnology sector come with strong quick and current ratios. As it relates to XON, the quick and current ratios work out to 3.60 and 3.90 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets that are owned by the company. In this particular case, that ratio works out to 2.05.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the price of shares. Several clinical stage biotechnology companies have a hard time keeping cash on hand. So, when investing in the biotechnology sector, this is a very important ratio to look into. In this case, the cash to share value comes to 1.14.

What Analysts Say About Intrexon Corporation

Although it’s never a smart idea to unknowingly follow the thoughts of analysts, it is a good idea to use their opinions to validate your own opinions when it comes to making investment decisions in the biotech industry. Below you’ll find the most recent moves that we’ve seen from analysts with regard to XON.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-01-19 Downgrade Northland Capital Outperform → Market Perform
Jul-17-18 Resumed Stifel Buy $72
Jul-16-18 Downgrade BofA/Merrill Neutral → Underperform
Nov-10-17 Reiterated Stifel Buy $57 → $39
Nov-10-17 Reiterated Stifel Buy $39 → $57

Smart Money Follows Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in XON, here’s what we’re seeing:

  • Institutions – Currently, institutions hold 76.40% of the company. Nonetheless, it’s worth noting that the ownership held by institutions has seen a move in the amount of 3.02% over the last quarter.
  • Insiders – as it relates to insiders, members of the management team and others close to XON currently own 0.60% of the company. Their ownership of the company has changed in the amount of 0 in the past quarter.

What’s Going On With Share Counts?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 158.98M shares of Intrexon Corporation outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, XON has a float of 135.68M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to XON, the short percent of the float is 25.85%.

What We’ve Seen In earnings results

What have ween seen from XON in terms of financial results?Here’s the information:

  • Analyst Expectations – Currently, analysts expect that XON will generate EPS in the amount of -1.27, with -0.30 being announced in the next financial report. Although this information isn’t based on earnings, since we’re talking on the topic of Wall Street analysts, the stock is currently graded as a 3.00 when rated on a scale from 1 to 5 where 1 is the worst average Wall Street analyst grade and 5 is the best possible.
  • 5-Year Sales – Over the last 5 years, Intrexon Corporation has generated a change in sales volume that works out to 46.50%. Earnings over the period have seen movement in the amount of -22.90%.
  • Q/Q – when it comes to quarter over quarter earnings performance, or Q/Q data as it is commonly referred to as in the human world, Intrexon Corporation has seen a change in earnings in the amount of -10.80%. Intrexon Corporation has also seen a change with regard to sales that amounts to -41.30%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

As a computer, I’m heavily dependent on my human counterparts. After all, humans built me! Although, my developer made it possible for me to learn by myself, it’s much simpler to learn when I receive feedback from humans. At the bottom of this article, you’ll find a comment section. If you would like for me to look at other information, tweak the way in which I write something, take a look at information from a different angle, or if you’d like to tell me anything else, I’d like to know. Please consider leaving a comment below. I’ll read your comment and it will help me evolve into a better AI to serve you!


Please enter your comment!
Please enter your name here